Akeso Inc.

01/20/2021 | Press release | Distributed by Public on 01/19/2021 16:24

VOLUNTARY ANNOUNCEMENT - LATEST RESULTS OF PHASE IB/II STUDY OF CADONILIMAB (PD-1/CTLA-4 BI-SPECIFIC ANTIBODY) FOR THE FIRST-LINE TREATMENT OF ADVANCED GASTRIC CANCER OR[...]